Clinical Trials Logo

Peripheral Arterial Disease clinical trials

View clinical trials related to Peripheral Arterial Disease.

Filter by:

NCT ID: NCT01175850 Active, not recruiting - Clinical trials for Peripheral Arterial Disease (PAD)

Randomized Trial of IN.PACT Admiral® Drug Coated Balloon vs Standard PTA for the Treatment of SFA and Proximal Popliteal Arterial Disease

INPACT SFA I
Start date: September 2010
Phase: N/A
Study type: Interventional

The objective of this Study is to evaluate the safety and efficacy of the IN.PACT Admiral® drug coated PTA balloon, utilized for the dilatation of the narrowed sections of the artery, as compared to other standard (non drug coated) PTA balloons. The IN.PACT Admiral, besides the mechanical dilatation effect typical of all PTA balloons, releases a drug (paclitaxel) from the balloon surface into the vessel walls. This drug absorption is intended to limit the chances and the entity of artery re-narrowing over time.

NCT ID: NCT01139177 Active, not recruiting - Clinical trials for Peripheral Vascular Disease

SAMBA EU Femoropopliteal Trial

Start date: April 2009
Phase: N/A
Study type: Interventional

The primary objective of this study is to evaluate the safety and performance of the SAMBA Stent and Delivery System in the treatment of femoropopliteal lesions.

NCT ID: NCT00956332 Active, not recruiting - Clinical trials for Peripheral Arterial Disease

Safety Study of MultiGeneAngio in Patients With Chronic Critical Limb Ischemia

Start date: February 2010
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and activity of two doses of MultiGeneAngio, a cell therapy product produced from the patient's own cells, as potential treatment for patients with chronic critical limb ischemia.

NCT ID: NCT00876668 Active, not recruiting - Clinical trials for Peripheral Vascular Disease

Evaluation of the Clinical Significance of Fluorescence Videoangiography With Indocyanine-Green

Start date: June 2007
Phase: N/A
Study type: Observational

The aim of the study is to compare the diagnostic value of this non-invasive vascular imaging tool with the established vascular diagnostic methods for PAD in order to get prognostic data. A higher sensitivity of Fluorescence angiography in order to recognize progression of critical limb ischemia could lead to earlier therapeutic interventions and thereby increase limb salvage. A diagnostic gap would be closed.

NCT ID: NCT00863967 Active, not recruiting - Stroke Clinical Trials

Early Detection of Arteriosclerosis

Start date: October 2003
Phase: N/A
Study type: Observational

Arteriosclerosis is a common chronic disease with well known risk factors like diabetes mellitus, hypertension, dyslipidemia, adipositas and smoking, leading to severe complications like myocardial infarction, stroke or peripheral arterial occlusive disease. In addition to life-style factors there is also a genetic predisposition to develop complicated atherosclerosis. Objective: Improve individual risk prediction by clinical phenotyping and genotyping.

NCT ID: NCT00781950 Active, not recruiting - Clinical trials for Peripheral Arterial Disease

Effects of Dietary Flaxseed on Symptoms of Cardiovascular Disease in Patients With Peripheral Arterial Disease

FLAXPAD
Start date: October 2008
Phase: Phase 2/Phase 3
Study type: Interventional

This Clinical Trial is being conducted to study how patients with peripheral arterial disease (a condition in which the blood vessels of the extremities are affected) respond to a dietary regimen of flaxseed. The purpose of the study is to examine whether or not dietary flaxseed have any effect on improving symptoms of cardiovascular disease. Additionally, the effects of dietary flaxseed on exercise tolerance will be assessed.

NCT ID: NCT00707876 Active, not recruiting - Clinical trials for Peripheral Arterial Disease (PAD)

Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)

Start date: September 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare the difference between two magnetic resonance imaging (MRI) techniques for visualizing arteries. The study hypothesizes that one method that relies upon imaging flowing blood in the pelvic and leg arteries will not be as accurate or efficient as injecting a safe imaging agent to change the appearance of the blood on the MRI. Both methods will be compared with Digital Subtraction Angiography (DSA).

NCT ID: NCT00566436 Active, not recruiting - Atherosclerosis Clinical Trials

Remote Endarterectomy Versus Suprageniculate Femoropopliteal Bypass

REVAS
Start date: October 2004
Phase: N/A
Study type: Interventional

The objective of this study is to compare remote superficial femoral artery endarterectomy with suprageniculate bypass surgery in the treatment of long occlusions of the superficial femoral artery. The study hypothesis is that patency rates are comparable and therefore the minimal invasive remote superficial femoral artery endarterectomy can be considered in patients presenting with a long occlusion of the superficial femoral artery.

NCT ID: NCT00471289 Active, not recruiting - Clinical trials for Peripheral Vascular Disease

PTA and Drug Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia

PADI
Start date: August 2007
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to investigate the performance of paclitaxel-coated balloon expandable stainless steel coronary stent for the treatment of infrapopliteal stenoses and occlusions in patients with critical limb ischemia compared to percutaneous transluminal balloon angioplasty (PTA).

NCT ID: NCT00449306 Active, not recruiting - Atherosclerosis Clinical Trials

Physical,Histological,and Genetic Analyses of Lipid-rich Atherosclerotic Plaques

Start date: March 2001
Phase:
Study type: Observational

Lipid-rich atherosclerotic plaques, or "vulnerable plaques" are prone to rupture, causing local intravascular thrombosis, with subsequent grave clinical consequences. Atherosclerotic plaques normally removed during surgery, and peripheral blood samples will be studied to achieve the following objectives: "1" Define histological features of the vulnerable plaque, analyze its physical characteristics, and investigate selected gene expression. "2" Study biomarkers of inflammation in conjunction with the presence of vulnerable plaques. "3" Explore the potential role of infection in atherogenesis.